0001140361-22-020572.txt : 20220525 0001140361-22-020572.hdr.sgml : 20220525 20220525161559 ACCESSION NUMBER: 0001140361-22-020572 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220523 FILED AS OF DATE: 20220525 DATE AS OF CHANGE: 20220525 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wise John Drayton CENTRAL INDEX KEY: 0001930805 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30739 FILM NUMBER: 22963089 MAIL ADDRESS: STREET 1: 700 US HIGHWAY 202/206 CITY: BRIDGEWATER STATE: NJ ZIP: 08807 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INSMED Inc CENTRAL INDEX KEY: 0001104506 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 541972729 STATE OF INCORPORATION: VA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 700 US HIGHWAY 202/206 CITY: BRIDGEWATER STATE: NJ ZIP: 08807 BUSINESS PHONE: 908-977-9900 MAIL ADDRESS: STREET 1: 700 US HIGHWAY 202/206 CITY: BRIDGEWATER STATE: NJ ZIP: 08807 FORMER COMPANY: FORMER CONFORMED NAME: INSMED INC DATE OF NAME CHANGE: 20000128 4 1 form4.xml FORM 4 X0306 4 2022-05-23 0001104506 INSMED Inc INSM 0001930805 Wise John Drayton 700 US HIGHWAY 202/206 BRIDGEWATER NJ 08807 true Chief Commercial Officer Common Stock 2022-05-23 4 A 0 26236 A 78137 D Stock Option (right to buy) 20.01 2022-05-23 4 A 0 164580 0 A 2032-05-23 Common Stock 164580 164580 D Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the grant, subject to Mr. Wise's continued employment with the Company on each vesting date. Each Restricted Stock Unit was received as a grant on May 23, 2022, for no consideration. In connection with the appointment of Mr. Wise as the Company's Chief Commercial Officer, the Company granted Mr. Wise an option to purchase a total of 164,580 shares of the Company's common stock under the Company's 2019 Incentive Plan. The option becomes exercisable based on the following vesting schedule: twenty-five percent (25%) vest on the first anniversary of the date of grant and twelve and one-half percent (12.5%) vest on each six month anniversary date thereafter through the fourth anniversary of the date of grant, subject to Mr. Wise's continued employment with the Company on each vesting date. /s/ John Drayton Wise, by Michael Smith as Attorney-in-fact 2022-05-25